Skip to main
  1. Stocks
  2. Tempus AI Inc
  3. Forecast
TEM

TEM Stock Forecast & Price Target

TEM Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 32%
Buy 26%
Hold 42%
Sell 0%
Strong Sell 0%

Bulls say

Tempus AI is supported by a powerful combination of accelerating diagnostics demand, expanding pricing leverage, and a fast-growing data franchise that together improved 3Q26 revenue to $411.5M, up 23.1% YoY, while adjusted EBITDA reached $25.6M and FY2026 revenue guidance was nudged to $1,600-1,605M. Oncology remains the core engine, with testing volume up 32% YoY to about 101,500 tests, xF order requisitions up 25% YoY, and higher ASPs expected from xT CDx migration and potential xF reimbursement gains later in 2027. The company’s moat is further reinforced by $550M+ of year-to-date data-licensing bookings, long-duration pharma contracts, and the Personalis acquisition, which should deepen MRD adoption and improve revenue visibility across multiple therapeutic areas.

Bears say

Tempus AI is viewed negatively because its diagnostics business faces execution and focus risks tied to a commercial partner, while demand from pharma customers can swing quarter to quarter as budgets and ordering priorities change. The company also depends on volatile ordering patterns and funding from the U.S. Department of Veterans Affairs for the Million Veteran Program, creating another layer of revenue uncertainty. Even if a deal-related upside exists, the core thesis remains fragile because closing risk could force PSNL to increase spending and investment, pressuring fundamentals rather than improving them.

TEM has been analyzed by 19 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 26% recommend Buy, 42% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.

TEM Analyst Forecast & Price Prediction

Get the latest TEM stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in TEM

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tempus AI Inc (TEM) Forecast

Analysts have given TEM a Buy based on their latest research and market trends.

According to 19 analysts, TEM has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $79.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $79.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tempus AI Inc (TEM)


TEM Analyst Forecast & Price Prediction

Get the latest TEM stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in TEM

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover TEM stock data and trends